Reach Out, stay Strong, Essentials (ROSE) for Telemedicine
Study Summary
This trial is testing two strategies to help support and sustain evidence-based practices for women Veterans in up to 20 VA facilities.
- Telemedicine
- High Cholesterol
- Prediabetes
- Diabetes
- Obesity
- Smoking
- Quality Improvement
- Pregnancy
- Implementation Science
- Postpartum Depression
- Cardiovascular Disease
- Heart Disease Risk Factors
- High Blood Pressure
- Prevention
Treatment Effectiveness
Effectiveness Progress
Study Objectives
6 Primary · 3 Secondary · Reporting Duration: 6 and 12 months
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
REP
1 of 2
EBQI
1 of 2
Active Control
Experimental Treatment
20 Total Participants · 2 Treatment Groups
Primary Treatment: Reach Out, stay Strong, Essentials (ROSE) · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age Any Age · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
California | 80.0% |
British Columbia | 20.0% |
What site did they apply to?
VA Greater Los Angeles Healthcare System, West Los Angeles, CA | 100.0% |
What portion of applicants met pre-screening criteria?
Met criteria | 66.7% |
Did not meet criteria | 33.3% |
How many prior treatments have patients received?
0 | 100.0% |
Frequently Asked Questions
How many participants has this clinical research reached its maximum capacity for?
"Affirmative. Perusal of clinicaltrials.gov reveals that this medical experiment, which was first publicized on October 21st 2021, is currently recruiting participants. Around 20 study volunteers are required from a single clinic site." - Anonymous Online Contributor
Is recruitment still open for the trial participants?
"As per the information stored on clinicaltrials.gov, this trial is seeking participants at present. This research initiative was initially created on October 21st 2021 and was recently revised in August 12th 2022." - Anonymous Online Contributor